1011 — China NT Pharma Co Share News
0.000.00%
Last trade - 00:00- HK$436.54m
- HK$794.62m
- CNY24.16m
Brief: China Nt Pharma Group Co Says Co To Cease Libod Sales & Promotion From Dec. 31, 2017
Brief: China NT Pharma Group Co says HY profit attributable to equity shareholders up 61.1 pct
Brief: China NT Pharma expects increase in net profit for six months ended 30 June 2017
Brief: China NT Pharma enters deal to issue 325 mln shares at HK$1.83 per share
Brief: China NT Pharma says FY net profit RMB 116.2 mln
Brief: China Nt Pharma obtains certification from China Food and Drug Administration
Brief: China NT Pharma Group says Xi Di Ke drug has obtained approval from China Food And Drug Administration to enter market
Brief: China NT Pharma Group updates on approval of new drug to enter market
Brief: China NT Pharma Group updates on unusual price movement of shares
Brief: Shanghai Jiaoda Onlly gets approval to acquire stake in China NT Pharma
Brief: China NT Pharma says co entered into a facilities agreement
Brief: China NT Pharma says co entered into asset purchase agreement with Novartis
Brief: China NT Pharma says trading halted pending release of announcement regarding signed agreements of acquisition
Brief: China NT Pharma Group Co Ltd updates on trading halt
Brief: China NT Pharma Group says in discussions regarding acquisition of pharmaceutical assets
Brief: China NT Pharma Group issues positive profit alert
Brief: Shanghai Jiaoda Onlly's units to acquire 9.4 pct stake in China NT Pharma
Brief: China NT Pharma says unit will establish Suzhou First Pharmaceutical Taizhou Co Ltd